Board, Nathan

Publications

Sort by

Co-Author Network

Cognate antigen engagement induces HIV-1 expression in latently infected CD4⁺ T cells from people on long-term antiretroviral therapy. Immunity. 2024 Academic Article GET IT
Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells. Immunity. 2024 Academic Article GET IT
Times cited: 9
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells. Nature immunology. 2024 Academic Article GET IT
Times cited: 11
A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design. The Journal of experimental medicine. 2023 Academic Article GET IT
Times cited: 5
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition. Immunity. 2022 Academic Article GET IT
Times cited: 16
TCR-mimic bispecific antibodies to target the HIV-1 reservoir. Proceedings of the National Academy of Sciences of the United States of America. 2022 Academic Article GET IT
Times cited: 16
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. PLoS pathogens. 2022 Academic Article GET IT
Times cited: 6
Engaging innate immunity in HIV-1 cure strategies. Nature reviews. Immunology. 2021 Review GET IT
Times cited: 51
Resolution of new daily persistent headache by a tumor necrosis factor alpha antagonist, Venlafaxine. 2019 GET IT